Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,434,532
+$166,156 QoQ
Shares Held
6,723
+4.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,167
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 17%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Belpointe Asset Management LLC holds $43,294,431 across 10 Drug Manufacturers - General names. AMGN ranks #7 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,672 | $11,744,542 | |
| 2 | LLY |
ELI LILLY & Co
|
7,399 | $8,874,583 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
125,071 | $7,206,591 | |
| 4 | JNJ |
Johnson & Johnson
|
16,266 | $4,131,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,259 | $3,888,281 | |
| 6 | PFE |
Pfizer Inc
|
156,552 | $3,769,772 | |
| 7 | AMGN |
Amgen Inc
This page
|
6,723 | $2,434,532 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,464 | $816,661 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,434,532 | 6,723 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $2,268,376 | 6,447 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $2,219,489 | 6,781 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $1,803,540 | 6,391 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,832,734 | 6,564 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,993,608 | 6,399 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $2,543,846 | 9,760 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,616,989 | 8,122 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,960,936 | 6,276 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,904,375 | 6,698 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,218,618 | 7,703 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,467,216 | 9,180 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,673,142 | 7,536 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,238,605 | 9,260 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,635,196 | 6,226 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,345,638 | 5,970 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,280,731 | 5,264 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,467,847 | 6,070 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,222,037 | 5,432 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,032,203 | 4,854 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,357,931 | 5,571 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,068,141 | 4,293 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,337,444 | 5,817 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,263,937 | 4,973 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,220,339 | 5,174 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,130,017 | 5,574 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||